The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Can anyone tell me what is the support and resistance level for this share price? I don't know why the share price has taken a tumble considering the positive update recently.
HAS has lost 18% since April,maybe showing the business cycle is turning flat again.
Anyone with an eye on the removals market will know that business is brisk
Good Article / Tip in yesterday’s Investor’s Chronicle: Bull points: Sizeable potential for UK profits to recover Recruitment markets improving in many regions Two consecutive quarters of better than expected net fee growth Valuation discount versus other large recruiters Bear points Australian business hit by resource market weakness Highly geared to economic recovery
Place to be atm. Should see healthy appreciation in SP over the next year.
No stopping this now...!!! Until I go and open my big mouth and post.
Sailing above 100 now....just.. Hold up there for today's close and we should continue up on Monday !!!
Guess I can't post the link. It's available at Earnings Impact
Guess I can't post the link. It's available at Earnings Impact
Just came across a transcript of the event soon after it ended! And moreover, without any registration!!! http://www.earningsimpact.com/Transcript/81909/HAS/Q4-2013-Earnings-Call
trade.....
looks like a sell....
big mill+ trade just in?...
Hays: UBS shifts target price from 120p to 110p and keeps a buy recommendation.
big trade....
Hays: Investec shifts target price from 90p to 94p and downgrades to add.
did you take some out of w,i did,just got a token gesture in there now,but ide like to get back in there at some point for obviouse reasons... got in txo 5 minutes before one of those mm bounces,ded funny..lol... musing..
lol..
todayyyyyyy
1st and 2nd posttttttttttttttttt
Hays: Credit Suisse takes target price from 85p to 95p reiterating its neutral rating.
Hays: Exane BNP ups target price from 95p to 107p and stays with its outperform rating.
Despite its difficulties, Hays' share price has risen 19 per cent since early September and the shares trade on 16 times JPMorgan Cazenove's forecast earnings. Admittedly, that's not pricey for a recruiter. Strip out cash and Michael Page's shares trade at around 25 times forecast earnings; although it's not so far off the rating of SThree (18 times earnings), which has become one of the best-performing recruiters. With a hefty debt pile, and its earnings forecast to slide as weak trading hits, expect the gains in Hays' share price to evaporate.
Hays isn't alone in its suffering. Michael Page, for instance, saw its third-quarter fee income drop 11.3 per cent year on year, with UK fees down 10.9 per cent. Yet some of Hays' rivals seem to be coping quite well. SThree, for example, grew its third-quarter income by 6 per cent year on year and Robert Walters saw its third-quarter fees grow 3 per cent on the same period last year. Those three rivals can also point to comforting cash piles - £50m at Michael Page, £6m at Robert Walters and £17m at SThree. Not so at Hays, which has net debt of £140m, which meant £5.7m of interest charges in 2011-12. That said, Hays has just completed a refinancing, involving the provision of a £300m five-year facility. Investors will also be unimpressed that last year management hacked back the year's total dividend by 53 per cent. The payout is forecast by JPMorgan Cazenove to remain flat in 2012-13 at 2.5p, meaning a prospective dividend yield of about 3 per cent; not dreadful, but not as good as, say, the 4.6 per cent yield on SThrees's shares.